83_FR_56547 83 FR 56328 - Basic Health Program; Final Administrative Order

83 FR 56328 - Basic Health Program; Final Administrative Order

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services

Federal Register Volume 83, Issue 219 (November 13, 2018)

Page Range56328-56347
FR Document2018-24673

This notice serves to announce that a Final Administrative Order related to the Basic Health Program (BHP) was issued to the States of New York and Minnesota on August 24, 2018.

Federal Register, Volume 83 Issue 219 (Tuesday, November 13, 2018)
[Federal Register Volume 83, Number 219 (Tuesday, November 13, 2018)]
[Notices]
[Pages 56328-56347]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-24673]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-2416-N]


Basic Health Program; Final Administrative Order

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice of Final Administrative Order.

-----------------------------------------------------------------------

SUMMARY: This notice serves to announce that a Final Administrative 
Order related to the Basic Health Program (BHP) was issued to the 
States of New York and Minnesota on August 24, 2018.

DATES: The Final Administrative Order was effective August 24, 2018.

FOR FURTHER INFORMATION CONTACT: Christopher Truffer, (410) 786-1264; 
Meg Barry, (410) 786-1536.

SUPPLEMENTARY INFORMATION:

I. Background and Provisions of the Notice

    The CMS Administrator issued a Final Administrative Order to set 
forth the revised payment methodology that applies to the Basic Health 
Program for 2018 only (HHS Revised BHP Payment Methodology). The 
Administrative Order is an agency action under 5 U.S.C. 551(13), issued 
pursuant to 5 U.S.C. 555(b) and (e).
    The HHS Revised BHP Payment Methodology modifies the existing 
methodology for 2018, which is set forth in the payment notice entitled 
``Basic Health Program; Federal Funding Methodology for Program Years 
2017 and 2018'' (81 FR 10091, February 29, 2016) (February 2016 Payment 
Notice). The modification involves the application of a Premium 
Adjustment Factor (PAF) that considers the premium increases in other 
states that became effective after the Centers for Medicare & Medicaid 
Services (CMS), an operating division of the U.S. Department of Health 
and Human Services (HHS), discontinued payments to issuers for cost-
sharing reductions (CSRs) provided to enrollees in qualified health 
plans (QHPs) offered on health insurance Exchanges.
    On July 6, 2018, pursuant to an amended stipulated order issued in 
State of New York v. U.S. Department of Health and Human Services, 18-
cv-00683 (S.D.N.Y. filed Jan. 26, 2018), CMS issued a Draft 
Administrative Order on which New York and Minnesota (the States) had 
an opportunity to comment. The States each submitted comments on August 
6, 2018. CMS considered those comments in issuing the Final 
Administrative Order, which adopts the HHS Revised BHP Payment 
Methodology for 2018 as set forth in the Draft Administrative Order.

II. Collection of Information Requirements

    This document does not impose information collection requirements, 
that is, reporting, recordkeeping, or third-party disclosure 
requirements. Consequently, review by the Office of Management and 
Budget under the authority of the Paperwork Reduction Act of 1995 (44 
U.S.C. 3501, et seq.) is not required.

III. Addendum

    We are publishing the Final Administrative Order as an addendum to 
this Notice.

    Dated: November 2, 2018.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
 BILLING CODE 4120-01-P

[[Page 56329]]

[GRAPHIC] [TIFF OMITTED] TN13NO18.099


[[Page 56330]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.100


[[Page 56331]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.101


[[Page 56332]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.102


[[Page 56333]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.103


[[Page 56334]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.104


[[Page 56335]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.105


[[Page 56336]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.106


[[Page 56337]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.107


[[Page 56338]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.108


[[Page 56339]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.109


[[Page 56340]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.110


[[Page 56341]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.111


[[Page 56342]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.112


[[Page 56343]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.113


[[Page 56344]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.114


[[Page 56345]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.115


[[Page 56346]]


[GRAPHIC] [TIFF OMITTED] TN13NO18.116


[[Page 56347]]


[FR Doc. 2018-24673 Filed 11-9-18; 8:45 am]
 BILLING CODE 4120-01-C



                                              56328                      Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices

                                              screenings? If yes, please explain the                  submissions containing private or                     methodology for 2018, which is set forth
                                              scheduling issue that is a barrier and                  proprietary information such as Social                in the payment notice entitled ‘‘Basic
                                              provide recommendations for how it                      Security numbers, medical information,                Health Program; Federal Funding
                                              could be overcome.                                      and/or inappropriate language.                        Methodology for Program Years 2017
                                                 6. Does concern about the                            Comments may be submitted on any                      and 2018’’ (81 FR 10091, February 29,
                                              confidentiality of medical information                  topic related to this action. All public              2016) (February 2016 Payment Notice).
                                              pose a barrier to participation? If this is             comments will be posted in the docket                 The modification involves the
                                              a barrier, then please provide                          for this action at https://                           application of a Premium Adjustment
                                              recommendations or suggestions for                      www.regulations.gov.                                  Factor (PAF) that considers the
                                              how it can be overcome.                                                                                       premium increases in other states that
                                                                                                      John J. Howard,
                                                 7. Does concern that the early                                                                             became effective after the Centers for
                                              identification of dust-related lung                     Director, National Institute for Occupational         Medicare & Medicaid Services (CMS),
                                                                                                      Safety and Health, Centers for Disease Control
                                              disease might adversely affect a miner’s                and Prevention.
                                                                                                                                                            an operating division of the U.S.
                                              career (e.g., prevent career advancement                                                                      Department of Health and Human
                                                                                                      [FR Doc. 2018–24700 Filed 11–9–18; 8:45 am]
                                              or the ability to get a new coal mining                                                                       Services (HHS), discontinued payments
                                                                                                      BILLING CODE 4163–19–P
                                              job) pose a barrier to participation? If                                                                      to issuers for cost-sharing reductions
                                              this is a barrier, then please provide                                                                        (CSRs) provided to enrollees in
                                              recommendations or suggestions for                                                                            qualified health plans (QHPs) offered on
                                                                                                      DEPARTMENT OF HEALTH AND
                                              how it can be overcome.                                                                                       health insurance Exchanges.
                                                                                                      HUMAN SERVICES
                                                 8. Does concern that early                                                                                   On July 6, 2018, pursuant to an
                                              identification of dust-related lung                     Centers for Medicare & Medicaid                       amended stipulated order issued in
                                              disease might affect subsequent                         Services                                              State of New York v. U.S. Department of
                                              eligibility for compensation through                                                                          Health and Human Services, 18–cv–
                                              Federal or State programs pose a barrier                [CMS–2416–N]
                                                                                                                                                            00683 (S.D.N.Y. filed Jan. 26, 2018),
                                              to participation? If this is a barrier, then                                                                  CMS issued a Draft Administrative
                                                                                                      Basic Health Program; Final
                                              please describe the specific                                                                                  Order on which New York and
                                                                                                      Administrative Order
                                              compensation programs and how                                                                                 Minnesota (the States) had an
                                              eligibility for them can be affected by                 AGENCY: Centers for Medicare &                        opportunity to comment. The States
                                              early detection of dust-related lung                    Medicaid Services (CMS), HHS.                         each submitted comments on August 6,
                                              disease. Please also provide                            ACTION: Notice of Final Administrative                2018. CMS considered those comments
                                              recommendations or suggestions for                      Order.                                                in issuing the Final Administrative
                                              how this barrier could be overcome.                                                                           Order, which adopts the HHS Revised
                                                 9. Does concern that personal finances               SUMMARY:   This notice serves to                      BHP Payment Methodology for 2018 as
                                              will require a miner to continue                        announce that a Final Administrative                  set forth in the Draft Administrative
                                              working despite early identification of                 Order related to the Basic Health                     Order.
                                              dust-related lung disease pose a barrier                Program (BHP) was issued to the States
                                              to participation? If this is a barrier,                 of New York and Minnesota on August                   II. Collection of Information
                                              please provide recommendations or                       24, 2018.                                             Requirements
                                              suggestions for how it can be overcome.                 DATES: The Final Administrative Order
                                                                                                                                                              This document does not impose
                                                 10. Are there any other barriers to                  was effective August 24, 2018.                        information collection requirements,
                                              participation that NIOSH should be                      FOR FURTHER INFORMATION CONTACT:                      that is, reporting, recordkeeping, or
                                              aware of?                                               Christopher Truffer, (410) 786–1264;                  third-party disclosure requirements.
                                                 Interested parties may participate in                Meg Barry, (410) 786–1536.                            Consequently, review by the Office of
                                              this activity by submitting written                     SUPPLEMENTARY INFORMATION:                            Management and Budget under the
                                              views, opinions, recommendations, and                                                                         authority of the Paperwork Reduction
                                              data. Comments received, including                      I. Background and Provisions of the
                                                                                                      Notice                                                Act of 1995 (44 U.S.C. 3501, et seq.) is
                                              attachments and other supporting                                                                              not required.
                                              materials, are part of the public record                   The CMS Administrator issued a
                                              and subject to public disclosure. Do not                Final Administrative Order to set forth               III. Addendum
                                              include any information in your                         the revised payment methodology that                    We are publishing the Final
                                              comment or supporting materials that                    applies to the Basic Health Program for               Administrative Order as an addendum
                                              you do not wish to be disclosed.                        2018 only (HHS Revised BHP Payment                    to this Notice.
                                              Although your name, contact                             Methodology). The Administrative
                                              information, or other information that                  Order is an agency action under 5 U.S.C.                Dated: November 2, 2018.
                                              identifies you in the body of your                      551(13), issued pursuant to 5 U.S.C.                  Seema Verma,
                                              comments will be on public display,                     555(b) and (e).                                       Administrator, Centers for Medicare &
                                              NIOSH will review all submissions and                      The HHS Revised BHP Payment                        Medicaid Services.
                                              may choose to redact or withhold                        Methodology modifies the existing                     BILLING CODE 4120–01–P
amozie on DSK3GDR082PROD with NOTICES1




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00055   Fmt 4703   Sfmt 4703   E:\FR\FM\13NON1.SGM   13NON1


                                                                         Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices                            56329

                                                                                                                    ADDENDUM




                                                                                    HHS "'"'v'"'""

                                                                           which       set




                                                                  and




                                                                             the HHS                                                                                 forth

                                                                  Ad:mir:istrathre Order.
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                                                       EN13NO18.099</GPH>




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00056   Fmt 4703   Sfmt 4725   E:\FR\FM\13NON1.SGM    13NON1


                                              56330                      Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices




                                                                           The result




                                                                 I.




                                                                                                                                             is




                                                                                                             standard health

                                                                              to enroll m                                          state's



                                                                                                                                                              make

                                                                                                                                                                            determine

                                                                 value
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                                                        EN13NO18.100</GPH>




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00057   Fmt 4703   Sfmt 4725      E:\FR\FM\13NON1.SGM   13NON1


                                                                         Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices                                    56331




                                                                                                                                                       other States with          to

                                                                                                                                                  nr•?vi.llen   to residents   other




                                                                                                                                                                               BHP




                                                                                                                                                                               BHP
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                                                               EN13NO18.101</GPH>




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00058   Fmt 4703   Sfmt 4725   E:\FR\FM\13NON1.SGM    13NON1


56332         Federal Register/Vol. 83, No. 219 /Tuesday, November 13, 2018 /Notices

        CMCS Informational Bulletin, Rasic Health Program; Federal Funding Methodclogy for

        Program Year 2018 (May 17, 2017).

                In October 2017, in response to an inquiry from HHS and the Treasury Department, the

        Attorney Cieneral concluded "that the best interpretation of the law is that the permanent

        appropriation for ‘refunding intemal revenue collections," 31 U.S.C. §$1324, cannot be used to

        fund the CSR payments to insurers authorized by 42 U.S.C. $ 18071."° Letter from Attorney Gen.

        Jefferson R. Sessions [to Sec‘y of Treasury Steven Mnuchin & Acting Sec‘y of HHS Don Wright

        at 1 (Oct. 11, 2017). The next day, HHS sent a memorandum to CMS explaining that "CSR

        payments are prohibited unless and until a valid appropriation exists." Memoranduwm from Acting

        Sec‘y of HHS Eric Hargan to Adm‘r of CMS Seema Verma, Payments to Issuers for Cost—Sharing

        Reductions (CSRs), at 1 (Oct. 12, 2017}." Because to date no CSR appropriation has been enacted,

        CMS is prohibited from making further payments of the CSR component of any BHP payment.

        EL      Frocedural Background

                Starting with the payment for the first quarter (Q1) of 2018 (which began on January 1,

        2018}, CMS stopped paying the CSR component of the quarterly BHP payments to New York and

        Minnesota. The States then sued the Secretary for dectaratory and injfunctive relief in the United

        States District Court for the Southern District of New York. See State ofNew York, et al, v. U.S.

        Department ofHealth and Human Services, 18—cv—00683 (S.D.N.Y. filed Jan. 26, 3018HHS

        understands the States® complaint to seek to compel HHS to either pay the CSR component of their

        2018 BHP payments as calculated under the methodology set forth in the February 2016 Payment




        ‘ The Attorney General‘s letter and the subsequent memmorandur from the Acting HHS Secretary are available at
        hittps//woywhhs. govisites/default/files/csr—payment—memo. pdf.


       Federal Register/Vol. 83, No. 219 /Tuesday, November 13, 2018 /Notices                                           56333

Notice, or take other actions that would ostensibly yield BHP payments for 2018 that are greater

than what CMS has paid.

         On May 2, 2018, the parties filed a stipulation requesting a 60—day stay of the litigation so

that HHS may issue an administrative order revising the 2018 BHP payment methodology. As a

result of the stipulation, the court dismissed the BHP litigation, althoughit retained jurisdiction to

enforce the stipulation and re—open the docket. On June 8, 2018, the parties revised their stipuiation

to amend the dates by which HHS would issue an administrative order.

IIl.     The HHS Revised BHMP Payment Methodology for 2018

         The HHS Revised BHP Payment Methodology, which applies only for 2018, modifies the

existing methodology for 2018 set forth in the February 2016 Payment Notice. The modification

involves the application of a premium adjustment factor (PAF) to calculate the PTC portion of the

BHP payment rates.

         Consistent with the February 2016 Payment Notice and prior years, the HHS Revised BHP

Payment Methodology for 2018 determines the States‘ BHP payments based on muiltiple rate cells"

applied to estimated BHP enrollment. CMS calculates the BHP payment rate for each rate cell in

two parts. The first part equals 95 percent of the estimated PTC that would have been paid if a

BHP enrollee in that rate cell had instead enrolled in a QHP through the State‘s Exchange. The

second part equals 95 percent ofthe estimated CSR payment that would have been made if a BHP

enrollee in that rate cell had instead enrolled in a QHP through the State‘s Exchange.



* Each rate cell represents a unique combination of age range, geographic area, coverage category (for example, self
only or two—adult coverage through BHP), household size, and income range as a percentage of FPL,. There is a
distinet rate cell for individuals in each coverage category within a particular age range who reside in a specific
geographic area and are in households ofthe same size and income range. In addition, the HHS Revised BHP Payment
Methodology aligns with a state‘s rules on age rating. Thus, in the case of a state that does not use age as a rating
factor on the Exchange, the BHP payment rates will not vary by age.


                                              56334                      Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices




                                                                                                                                                        IRF




                                                                     •
                                                                     •
                                                                     •
                                                                     •
                                                                     •
                                                                     •
                                                                     •
                                                                     •
                                                                     •
                                                                     •
                                                                     •




                                                                    the BHP
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                                              EN13NO18.104</GPH>




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00061   Fmt 4703   Sfmt 4725   E:\FR\FM\13NON1.SGM   13NON1


        Federal Register/Vol. 83, No. 219 /Tuesday, November 13, 2018 /Notices                                     56335

the payment formula based on consideration of the experience of other states regarding enrollee

participation in metal tiers.

         The total BHP payment rate for each rate cell equals the sum of the PTC and CSR parts.

CMS multiplies the rate for each rate cell by the number of BHP enrollees in that cell—that is, the

number of enrollees that meet the criteria for each rate cell (£,4,4..)—to calculate the total monthly

BHP payment to the state (PMT). The equation for this calculation is:

                         PMT = Z{(wcmm + CSRageni) * EageRil
In this equation, CMS assigns a value ofzero to the CSR part of the BHP payment rate calculation

(CSRaq,4i) because there is presently no available appropriation from which CMS can make the

CSR portion of any BHP paymflnt.3

         Determination of the PAF

         The PAF considers the premium increases in other states that took effect after CMS

discontinued payments to issuers for CSRs provided to enrollees in QHPs offered on state

insurance Exchanges. The PAF is authorized by ACA § 1331(d)(3)(A)(ii), which says that the

determination of the BHP payment amount "shall take into consideration the experience of other

States with respect to participation in an Exchange and such [PTCs) and [CSRs]) provided to

residents of the other States."

         CMS has calculated the PAF for each BHP state for 2018 as follows:

    a    CMS sought to collect QHP issuer information from QHP issuers in each state and the

         District of Columbia, and then determine the premium adjustment that the responding QHP



* in the event that an appropriation for CSRs for 2018 is made, CMS would reconsider whether to zero—out the CSR
part of the BHP payment rate calculation (CSR,4,4;) and to include the FPAF in the HHS Revised BHP
Methodology.


                                              56336                      Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices




                                                                        •




                                                                         •


                                                                         •


                                                                             PAF

                                                                         •                                      1.188.

                                                                         •                                      1.188.
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                                              EN13NO18.106</GPH>




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00063   Fmt 4703   Sfmt 4725   E:\FR\FM\13NON1.SGM   13NON1


                  u&               —                    y



         In general, CMS has determined these specific true—up payments by calculating the total

BHP payments for the first, second, and third quarters of 2018 under the HHS Revised BHP

Methodology set forth in this Final Order and subtracting the amounts of the payments already

made for those quarters {including the Q2 supplemental payments made to the states on or about

May 14, 2018). If a state already received a total quarterly BHP payment exceeding the quarterly

payment that CMS calculated under the HHS Revised BHP Methodology set forth in this Final

Order, then CMS will offset the overpayment against the next quarterly payment to the state.

         CMS will make any future reconciliation payments (%e., those payments calculated

retrospectively and based on final BHP enroliment for 2018, as compared to the quarterly

payments based on estimated enrollment) using the HHS Revised BHP Methodology set forth in

this Final Order, and otherwise consistent with the February 2016 Payment Notice.

I¥.      Facts and Data

         To determine the PAF described above, CMS requested information from QHP issuers in

each state serviced by a Federally—facilitated Exchange (FFE) to determine the premium

adjustment those issuers made to each silver level plan offered through the Exchange in 2018 to

account for the end of CSR payments. Specifically, CMS requested information showing the

percentage change that QHP issuers made to the premium for each of their silver level plans to

cover benefit expenditures associated with the CSRs, given the lack of CSR payments in 2018,

This percentage change was a portion of the overall premium increase from 2017 to 2018.

         According to CMS records, there are 1,233 silver—level QHPs operating on Exchanges in

2018,.   COf these 1,233 QHPs, 318 QHPs {(25.8 percent) responded to CMS‘s request for the

percentage adjustment applied to silver—level QHP premiums in 2018 to account for the

discontinuance of the CSRs. These 318 QHPs operated in 26 different states with 10 of those


                                              56338                      Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices




                                                                  v.




                                                                                                                               10
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                                              EN13NO18.108</GPH>




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00065   Fmt 4703   Sfmt 4725   E:\FR\FM\13NON1.SGM   13NON1


                       u&                —                    y



Exchange and such [PTCs]| and [CSRs] provided to residents of the other States," as required by
ACA §     1331(d)(3X¥A)i1y.
          New York‘s enumerated comments submitted on August 6, 2018 and CMS‘ responses
follow:
   1. The methodology fails to detail how HHS accounts for the experiences of other states in
          estimating the median adjustment for silver—level QHPs nationwide. Specifically, the
          methodology does not set forth how CMS accounted for relative distributions of income,
          differences in rating rules, actual claims experiences, and differential approaches to
          adjust for the loss of CSRs.

          Response: The methodotogy described in the Draft Order adequately accounts for the
          experience ofother states with regard to the discontinuance of the CSR payments to QHPs.
          By surveying QHPs, we have taken into account the experience of states in the aggregate.
          Accounting for the impact of the discontinuance in each state at the level of detail New
          York suggests would be impractical, if not impossible, given (i) the multitude of state—
          specific factors noted above and (ii) the lack of clarity and transparency in how individual
          QHP issuers took these factors into account in making any adjustments to the QHP
          premiums.

          On page 7 of the Draft Administrative Order, CMS outlines how it will determine the PAF
          and claims that it will "collect QHP fssuer information from QHP issuers in each state and
          the District of Columbia"®" to account for the discontinuation of CSR payments to QHP
          issuers. However, page 9 of the Draft Administrative Order indicates that CMS only
          requested information from QHP issuers in states serviced by Federally—facilitated
          Exchanges ("FFEs"). As CMS itself seems to recognize, it cannot exclude states with
          State—based Exchanges ("SBEs") — particularly since the BHMPs are only in states with
          SBEs, CMS must provide clarity on whether it only reached out to QHP issuers in FFEs —
          and if so, provide an explanation as to why it did so and how that impacts its ability to
          accurately establish a nationwide median.,

          Response: We disagree that surveying QHP issuers participating in SBEs is required to
          accurately establish a nationwide median, as we do not belifeve that QHP issuers in SBEs
          responded to the discontinuation of CSR payments differently than QHP issuers in FFEs.
          That is, we do not believe that the mere type of entity managing the Exchange, standing
          alone, affected QHP issuer behavior.

          Based on our survey of QHP issuers, we found that the mean premium adjustments by state
          ranged from 3.9 percent to 29.6 percent in states operating SBEs or SPEs in 2018 {9 states,
          excluding New York) and the median of these was 15.0 percent. The mean premium
          adjustments by state for states with FFEs in 2018 (15 states) were 9.25 percent to 32.5
          percent, and the median of these was 19.9 percent. We believe that these mean premium
          rate increase ranges and medians are reasonably similar between the SBE/SPE states and
          FFE states, and that there is no apparent bias between the results. We also note to the


                                                   11


            u&                —                     y



extent there is any difference between the premium rate increases and medians found in
SBE/SPE states and FFE states, the rate increases were lower in SBE/SPE states.

CMS was able to compile this rate increase data because CMS requested information from
all OHP issuers participating in FFEs and SPEs. Becausemany ofthese issuers also offered
OHPs in SBEs, they also reported adjustments for those QHPsto CMS.. Thus, while CMS
did not directly solicit information from issuers that only offered QHPs on SBEs, CMS did
receive adjustment information for QHPs offered on SBEs. Therefore, we do not believe
that this approach impacted our ability to accurately establish a nattonwide median.

The Draft Order states that the PAF is derived only from a very small pool of siltver—level
OHPs (25.8%) and does not provide information regarding how many different states that
represents. Relying on a small fraction of issuers‘ rate adjustments from an unspecified
number of states does not appear to be sufficient to calculate & "nationwide median
adjustment" as provided for in the Proposed Methodology. CMS should provide additional
information on the issuers whose information was considered and why that survey is
adequate to establish a natonwide median,

Response: We disagree that the PAF is derived from a "very small pool" ofsilver—level
(HPs. On the contrary, QHP issuers representing 26 differert states responded to our
request for information, including 10 states that operated SBEs/SPEs in 2018. We do not
believe, and have no reason to believe, there is any difference in the premium adjustments
made hy QHP issuers that did report and those that did not report,

The QHPs (and the states) represented in the sample—are reasonably representative of the
nattionwide—results. Fundamentally, QHPs faced similar costs in cach state‘s Exchange,
because the underlying actuarial values of the silver—level plans and the CSRs were the
same. While there may be some underlying variations state—to—state (for example, the
relative number of people receiving CSRs compared to those not receiving CSRs) and some
states may have provided diffferent Instructions to QHPs, we received a range of results that
adequately captured the experience across the states and various QHPs:

Also, the results of the survey based on the responses that we received were generally
consistent with public domain information regarding GHP issuers‘ adjustments to
premiums to account for the discontinuance of CSR payments. For example, the Kaiser
Family Foundation surveyed QHP issuers in October 2017 and found that siIver—level QHP
premiums were adjusted between 0 and 38 percent for 2018 due to the discontinuance of
the CSR payments, with a median adjustment of about 15 percent, (See Kaiser Family
Foundation, "How the Loss of CostSharing Subsidy Payments is Affecting 2018
Premiums," October 2017; hitp/es kLorg/attachment‘Issue—Bref—How—the—Loss—of—
CostSharing—Subsidy—Payments—ts—Affecting—2018—Premiums).

In short, the response rate was sufficient to develop the nationwide median adjustment for
use in the payment methodology.


                u&              —                     y



4. In describing the PAF, CMS states that "outlier" QHPs were not included in the factor.
   However, the Draft Order does not define "outlter" or provide any guidance as to when an
   adjustment would be excluded on such grounds. "Outlier" should be defined.

   Response: CMS considered outliers to be adjustments that were (1) negative or (2)
   excessively high (for example, above 100 percent). Of the responses CMS received, we
   considered only 1 an outlier (reporting a 2,000 percent increase), and we suspect this was
   a typographical error in reporting.

   CMS states that QHP issuers that made no CSR adjustment will count as "0" in determining
   the median adjustment made to all silver—level QHPs nationwide. New York disagrees
   with this determination because including these QHP issuers in the adjustment is contrary
   to the purpose of the BHP payment methodology. Only issuers that adjusted premiums in
   response to the CSR defunding should be included in the calculation of the PAF factor, as
   this is the relevant comparison group when adjusting for the experience of other states. By
   including issuers with no CSR adjustments, HHS is not calculating the PTC subsidy
   amount that "would have been provided" to BHP—eligible individuals in New York if they
   had enrolied in QHPs, as required by statute, See 42 U.S.C. § 18051(d)(3)(A)(iy; 42 C.FR.
   §600.605(a)(1 }—(2).

   Response: CMS, in accordance with ACA § 1331, sought to account for all states‘
   experience in developing the PAF adjustment. No QHP issuers reported an adjustment of
   0 for stiver—evel QHPs on Exchanges, and therefore no 0 adjustments were included in the
   calculation. That said, some states allowed or required (HP issuers to make no adjustment
   to 23018 premium amounts to account for the discontinuation of CSR payments, So we
   believe that "0%" adjustments would be acceptable because they reflect the experience of
   issuers in other states. Again, though, CMS made no such adjpestments,

   The Proposed Methodology does not address issuance ofquarterly payment letters to states.
   Payment letters providing the states with details on how the payment methodology is
   applied to the state‘s estimated enrollment submission for the following quarter should
   resume in August 2018 for quarter 4.

   Response: CMS intends to provide quarterty payment letters to the States, as it has done in
   the past, for future quarters starting with €24 of 2018.

   Comments from Minnesota with Responses from CMS

 ._ In section TV of the draft order, under the heading "Facts and Data," CMS explains that it
   requested information from issuers in each state serviced by a federally—facilitated
   marketplace. From the 25.8% of those issuers that responded, CMS calculated a median
   nationwide adjustment of 20 percent. It appears that CMS did not attempt to obtain data
   from issuers in state—based marketplaces and in state—partnership marketplaces. The draft
   order does not explain whether and how CMS plans to obtain data from issuers in these
   states to include in the calculation of the nationwide median adjustment. We recommend



                                            13


that CMS survey all issuers, especially those in state—hbased marketplaces, before finalizing
the value ofthe premium adjustment factor. As is, the lack ofrepresentation from the plans
in state—based and partnership marketplaces that are more representative of Minnesota‘s
individual insurance market is likely masking the nattionwide expenience.

Response: We disagree that surveying QHP issuers participating in SBFs or SPF3s is
retuired to accurately establish a nattonwide median, as we do not belteve that QHP issuers
in SBEs or SPEs responded to the discontinuation of CSR payinents differently than QHP
issuers in FFEs. That is, we do noot believe that the mere type of entity managing the
Exchange, standing alone, affected (OHF issuer behavior:

Based on our survey of QHP issuers, we found that the mean premfur adjustments by state
faniged from 3.9 percent to 19.6 pervent in #tates operating SBEs or SPE# in 2018 (9 states,
excluding New York) and the median of these was 15.0 percent. The mean premiom
adjustments by—state for states with FFEs in 2018 (15 states) wore 9.25 pergent to 37.5
percent, and the median ofthese was 19.9 percent, We believe that these mean premium
rate increase fanges and medians are reasongbly similar between the SBE/SPE states and
FFE states, and that there is no apparent bigs between the results,. We also note to the
extent there is any difference between the premlum rate increases and medians found in
SRE/SPE states and FFE atates, the rate increases were lower in SRE/SPE states.

CMS was able to compile this rate increase data becauseCMS requested information from
all QHP issuers participating in FFEs and SPEs. Becausemany ofthese issuers also offered
QHPs in SBEs, they also reported adjustments for thosw OHPs to CMS. Thus, whileCMS
did not directly solicit information from issuers that only offered QHPs on SBEs, CMS did
recéive adjustment information for QHPs offered on SBEs. We do aot believe that this
approach impacted our ability to accurately establish a nationwide median.

QHP issuers representing 26 different states responided to our request for information,
including 10 states that operated SREs or SPEs in 2018. We do not believe, and have no
reason to believe, there is any difference in the premium adjustments made by OHP issuers
that did report and those that cid not report.

Also, the—results of the survey based on the responses that we received were generally
consistent with public domain information regarding QHP lsswers‘ adjuostments to
premtums to account for the discontinuance of CSR payments. Forexample, the Kgiser
Farmly Foundation surveyed QHP issuers in October 2017 and found that sitver—level QHF
preminums were adjusted between 0 and 38 percent for 2018 due to the discontinuance of
the CSR payments, with a median adjustment of about 15 percent. (See Kaiser Family
Foundation, "How the Loss of CostSharing. Subsidy Payments is Affecting 2018
Premiums," October 2017 http/fleskfforpattachment{ssue—Bnef—How—the—Loss—of>
                                                     ~Prempums). In short, the response rate
was sufficient to develop the nationwide median adjustment for use in the payment
methodology.


                 u&               —                    y



2. Further, it is especially important that the factor determined for 2018 is based on data from
   a population including all the sitver—level issuers nationwide, and that the 1.188 forms the
   base for the future adjustments because QHP issuers will not be able to continue calculating
   the difference in premiums before and after the CSR loss after the 2018 coverage year. If
   it is not CMS" intent to obtain data from all issuers or from a more representative sample
   of issuers, then we suggest that the final methodology should itemize the exclusions and
   justify the resulting adjustment factor as a reasonable approximation of the experience in
   other states, including those not sampled.,

   Response: The QHPs ({and the states) represented in the sample are reasomably
   representative ofthe nationwide results, Fundamentally, QHPs faced similar costs in each
   state exchange, because the underlying actuarial values of the silver—level plans and the
   CSRs were the same. While there may be some underlying variations state—to—state (for
   example, the relative number of people receiving CSRs compared to those not receiving
   CSRs) and some states may have provided different instructions to QHMPs, we received a
   range of results that adequately captured the experience across the states and various QHPs.

   CMS has not committed to a methodology for 2019 or beyond at this point in time.

3. On page 7 of the draft order, CMS notes that issuers that reported a zero increase were
   counted in the calculation of the median, but that CMS reserves the right to exclude
   reported amounts that are negative, outliers, or unreasonable.    Including zero increases is
   inconsistent with the purpose of this adjustment factor, given that a zero increase is likely
   the result of decisions some states made to the detriment of policyholders. Also, for those
   amounts that were determined to be "outliers" or "unreasonable," CMS should itemize and
   explain those amounts that were excluded.

   Response: CMS, in accordance with ACA $ 1331, sought to account for all states‘
   experience in developing the PAF adjustment. No QHP issuers reported an adjustment of
   0 for silver—level QHPs on Exchanges, and therefore no 0 adjustments were included in the
   calculation. That said, some states allowed or required QHP issuers to make no adjustment
   to 2018 premium amounts to account for the discontinuation of CSR payments, So we
   believe that "0%" adjustments would be acceptable because they reflect the experience of
    issuers in other states. Again, though, no such adjustments were made,

    CMS considered outlhiers to be adjustments that were (1) negative or (2) excessively high
    {(for example, above 100 percent}. Of the responses CMS received, we considered only 1
    an outlier (reporting a 2,000 percent increase), and we suspect this was a typographical
    error in reporting.

4. Finally, we urge CMS to finalize the payment methodology for 2019 as soon as possible.

    Response: CMS concurs, and CMS is at work on the 2019 and 2020 BHP payment
    methodologies.




                                             15


                u&               —                       y



Y¥L.   BHP Payments for Q1—Q3 2018 Under The HHS Revised Payment Mcthodology

       Using the HHS Revised BHP Payment Methodology with PAF values of 1.188 for both

New York and Minnesota as finalized in this Administrative Order and with enrollment data

previously provided by the States, CMS calculates the States" BHP payments for the first three

quarters of 2018 as listed in the tables below. These tables include the quarterly BHP payments

CMS has made for Q1—Q3 2018 to New York and Minnesota, payment amounts for the same

periods calculated under the HHS Revised Payment Methodology, 2 supplemental payments

paid to the States in May 2018, and the resulting true—up payments CMS will make to the States

by September 7, 2018.




                                     {Intentionally Left Blank]


                                                                         Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices                               56345




                                                                                                                                                                     Difference
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                                                          EN13NO18.115</GPH>




                                         VerDate Sep<11>2014   17:34 Nov 09, 2018   Jkt 247001   PO 00000   Frm 00072   Fmt 4703   Sfmt 4725   E:\FR\FM\13NON1.SGM   13NON1


payment rates to the States.

        Wa are finalizing these reviged payment amounts for the first three quarters of 3018 in this

Final Administrative Order. in addifion, CMS will use the finalized monthly BHP payment rates

determined under the HHS Revised BHP Payment Methodology finalized in this Admimistrative

OQrder to develop the States‘ reconciled BHP payments (using actual enrollment date the States

submit after the close of the benefit yearr.




                                               ififiifimsfl.fih day of Ajigust, 2018.




                                                                                   a d
                                                        \ ppma) |prw—_ .
                                                        ;   .         1   j

                                               Seema Wmfia Admt            ator
                                               Centers for Medicare &Medicaid Services
                                               U.S. De L;%sr%rzwt‘fi of Health and Human Services
                                                 yous
                                                 Bs


                                                                                   Federal Register / Vol. 83, No. 219 / Tuesday, November 13, 2018 / Notices                                                                                   56347

                                              [FR Doc. 2018–24673 Filed 11–9–18; 8:45 am]                                 ACTION:       Notice.                                                        Reduction Act of 1995 (44 U.S.C. 3507).
                                              BILLING CODE 4120–01–C                                                                                                                                   The OMB control number and
                                                                                                                          SUMMARY:    The Food and Drug
                                                                                                                                                                                                       expiration date of OMB approval for
                                                                                                                          Administration (FDA) is publishing a
                                                                                                                                                                                                       each information collection are shown
                                              DEPARTMENT OF HEALTH AND                                                    list of information collections that have
                                                                                                                          been approved by the Office of                                               in table 1. Copies of the supporting
                                              HUMAN SERVICES                                                                                                                                           statements for the information
                                                                                                                          Management and Budget (OMB) under
                                              Food and Drug Administration                                                the Paperwork Reduction Act of 1995.                                         collections are available on the internet
                                                                                                                          FOR FURTHER INFORMATION CONTACT: Ila
                                                                                                                                                                                                       at http://www.reginfo.gov/public/do/
                                              [Docket Nos. FDA–2017–N–0558; FDA–                                                                                                                       PRAMain. An Agency may not conduct
                                              2017–N–1315; FDA–2011–N–0776; FDA–                                          S. Mizrachi, Office of Operations, Food
                                                                                                                          and Drug Administration, Three White                                         or sponsor, and a person is not required
                                              2018–N–3038; FDA–2018–N–0405; FDA–
                                              2014–N–1048; FDA–2011–N–0908; FDA–                                          Flint North, 10A–12M, 11601                                                  to respond to, a collection of
                                              2011–N–0920; and FDA–2018–N–1857]                                           Landsdown St., North Bethesda, MD                                            information unless it displays a
                                                                                                                          20852, 301–796–7726, PRAStaff@                                               currently valid OMB control number.
                                              Agency Information Collection                                               fda.hhs.gov.
                                              Activities; Announcement of Office of
                                                                                                                          SUPPLEMENTARY INFORMATION: The
                                              Management and Budget Approvals
                                                                                                                          following is a list of FDA information
                                              AGENCY:        Food and Drug Administration,                                collections recently approved by OMB
                                              HHS.                                                                        under section 3507 of the Paperwork

                                                                                                TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
                                                                                                                                                                                                                             OMB control   Date approval
                                                                                                                      Title of collection                                                                                       No.           expires

                                              Disclosures in Professional and Consumer Prescription Drug Promotion ..............................................................                                              0910–0860       9/30/2020
                                              Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads ..........................                                                            0910–0861       9/30/2020
                                              Reclassification Petitions for Medical Devices ........................................................................................................                          0910–0138       9/30/2021
                                              Request for Samples and Protocols ........................................................................................................................                       0910–0206       9/30/2021
                                              Medical Device Recall Authority ..............................................................................................................................                   0910–0432       9/30/2021
                                              Food Safety, Health, and Diet Survey .....................................................................................................................                       0910–0345      10/31/2020
                                              Medical Device Labeling Regulations .....................................................................................................................                        0910–0485      10/30/2021
                                              GFI: Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees                                                                     0910–0581      10/31/2021
                                              Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human
                                                Food .....................................................................................................................................................................     0910–0751      10/31/2021
                                              Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for
                                                Animals .................................................................................................................................................................      0910–0789      10/31/2021



                                                Dated: November 5, 2018.                                                  Prescription Drug User Fee Act (PDUFA                                        information, please refer to https://
                                              Leslie Kux,                                                                 VI) and the 21st Century Cures Act                                           www.fda.gov/AboutFDA/
                                              Associate Commissioner for Policy.                                          (Cures Act) by soliciting comments on                                        WorkingatFDA/BuildingsandFacilities/
                                              [FR Doc. 2018–24609 Filed 11–9–18; 8:45 am]                                 Drug Development Tool Qualification at                                       WhiteOakCampusInformation/ucm241
                                              BILLING CODE 4164–01–P
                                                                                                                          FDA related to the qualification process                                     740.htm.
                                                                                                                          under section 507 of the Federal Food,                                          You may submit comments as
                                                                                                                          Drug, and Cosmetic Act (FD&C Act);                                           follows. Please note that late, untimely
                                              DEPARTMENT OF HEALTH AND                                                    discussing taxonomy for biomarkers and                                       filed comments may not be considered.
                                              HUMAN SERVICES                                                              related concepts used in drug                                                For timely consideration we request that
                                                                                                                          development; and planning activities to                                      electronic comments be submitted on or
                                              Food and Drug Administration                                                define a framework with appropriate                                          before January 31, 2019. The https://
                                                                                                                          standards and scientific approaches to                                       www.regulations.gov electronic filing
                                              [Docket No. FDA–2018–N–4100]
                                                                                                                          support qualification for a specified                                        system will accept comments until
                                              Drug Development Tool Process Under                                         context of use.                                                              11:59 p.m. Eastern Time on January 31,
                                              the 21st Century Cures Act and                                                                                                                           2019. Comments received by mail/hand
                                                                                                                          DATES:  The public meeting will be held
                                              Prescription Drug User Fee Act VI;                                                                                                                       delivery/courier (for written/paper
                                                                                                                          on December 11, 2018, from 9 a.m. to 5
                                              Public Meeting; Request for Comments                                                                                                                     submissions) will be considered timely
                                                                                                                          p.m. Submit either electronic or written
                                                                                                                                                                                                       if they are postmarked or the delivery
                                                                                                                          comments on this public meeting by
                                              AGENCY:        Food and Drug Administration,                                                                                                             service acceptance receipt is on or
                                                                                                                          January 31, 2019. See the
                                              HHS.                                                                                                                                                     before that date.
                                                                                                                          SUPPLEMENTARY INFORMATION section for
                                              ACTION: Notice of public meeting;                                           registration date and information.                                           Electronic Submissions
                                              request for comments.
                                                                                                                          ADDRESSES:  The public meeting will be                                         Submit electronic comments in the
                                              SUMMARY:   The Food and Drug                                                held at FDA White Oak Campus, 10903                                          following way:
amozie on DSK3GDR082PROD with NOTICES1




                                              Administration (FDA or the Agency) is                                       New Hampshire Ave., Bldg. 31, Rm.                                              • Federal eRulemaking Portal:
                                              announcing a public meeting entitled                                        1503A (the Great Room), Silver Spring,                                       https://www.regulations.gov. Follow the
                                              ‘‘Drug Development Tool Process under                                       MD 20993. Entrance for the public                                            instructions for submitting comments.
                                              the 21st Century Cures Act and PDUFA                                        meeting participants (non-FDA                                                Comments submitted electronically,
                                              VI.’’ This public meeting is intended to                                    employees) is through Building 1 where                                       including attachments, to https://
                                              fulfill commitments made by FDA                                             routine security check procedures will                                       www.regulations.gov will be posted to
                                              under the sixth authorization of the                                        be performed. For parking and security                                       the docket unchanged. Because your


                                         VerDate Sep<11>2014         17:34 Nov 09, 2018          Jkt 247001       PO 00000       Frm 00074        Fmt 4703       Sfmt 4703       E:\FR\FM\13NON1.SGM               13NON1



Document Created: 2018-11-10 03:18:25
Document Modified: 2018-11-10 03:18:25
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of Final Administrative Order.
DatesThe Final Administrative Order was effective August 24, 2018.
ContactChristopher Truffer, (410) 786-1264; Meg Barry, (410) 786-1536.
FR Citation83 FR 56328 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR